Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000083

Director sold 1,666 shares at an average $51.70 ($86,139)

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-18 Sale : show line 1 in the form −806 $51.26 $41,316 132,025 D
2021-08-18 Sale : show line 2 in the form −860 $52.12 $44,823 131,165 D
Open-market sales · 1,666 sh · avg $51.70 · $86,139
Loading xslF345X03/wf-form4_162949494285003.xml…